Wenk MR (2005) The emerging field of lipidomics. Nat Rev Drug Discov 4(7):594–610
Article
PubMed
CAS
Google Scholar
Perrotti F, Rosa C, Cicalini I, Sacchetta P, Del Boccio P, Genovesi D et al (2016) Advances in lipidomics for cancer biomarkers discovery. Int J Mol Sci https://doi.org/10.3390/ijms17121992
Article
PubMed
PubMed Central
Google Scholar
Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP et al (2004) Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prevent 13(7):1185–1191
CAS
Google Scholar
Lin L, Ding Y, Wang Y, Wang Z, Yin X, Yan G et al (2017) Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism. Hepatology 66(2):432–448
Article
PubMed
CAS
Google Scholar
Giskeodegard GF, Hansen AF, Bertilsson H, Gonzalez SV, Kristiansen KA, Bruheim P et al (2015) Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia. Br J Cancer 113(12):1712–1719
Article
PubMed
PubMed Central
CAS
Google Scholar
Babahosseini H, Roberts PC, Schmelz EM, Agah M (2012) Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. In: Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society IEEE engineering in medicine and biology society annual conference. pp. 2436–9
Nagahashi M, Tsuchida J, Moro K, Hasegawa M, Tatsuda K, Woelfel IA et al (2016) High levels of sphingolipids in human breast cancer. J Surg Res 204(2):435–444
Article
PubMed
PubMed Central
CAS
Google Scholar
Van Brocklyn JR (2007) Sphingolipid signaling pathways as potential therapeutic targets in gliomas. Mini Rev Med Chem 7(10):984–990
Article
PubMed
Google Scholar
Yang MH, Rampal S, Sung J, Choi YH, Son HJ, Lee JH et al (2013) The association of serum lipids with colorectal adenomas. Am J Gastroenterol 108(5):833–841
Article
PubMed
CAS
Google Scholar
Lv JGD, Zhang Y, Wu D, Shen L, Wang X (2018) Heterogeneity of lipidomic profiles among lung cancer subtypes of patients. J Cell Mol Med. https://doi.org/10.1111/JCMM.13782
Article
PubMed
PubMed Central
Google Scholar
Wang X (2018) Clinical trans-omics: an integration of clinical phenomes with molecular multiomics. Cell Biol Toxicol 34(3):163–166
Article
PubMed
CAS
Google Scholar
Harkewicz R, Dennis EA (2011) Applications of mass spectrometry to lipids and membranes. Annu Rev Biochem 80:301–325
Article
PubMed
PubMed Central
CAS
Google Scholar
Yang L, Cui X, Zhang N, Li M, Bai Y, Han X et al (2015) Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers. Anal Bioanal Chem 407(17):5065–5077
Article
PubMed
CAS
Google Scholar
Shen S, Yang L, Li L, Bai Y, Cai C, Liu H (2017) A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer. J Chromatogr B 1068–1069:41–48
Article
CAS
Google Scholar
Zhou X, Mao J, Ai J, Deng Y, Roth MR, Pound C et al (2012) Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS ONE 7(11):e48889
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim H, Min HK, Kong G, Moon MH (2009) Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem 393(6–7):1649–1656
Article
PubMed
CAS
Google Scholar
Saliba AE, Vonkova I, Gavin AC (2015) The systematic analysis of protein–lipid interactions comes of age. Nat Rev Mol Cell Biol 16(12):753–761
Article
PubMed
CAS
Google Scholar
Bagam P, Singh DP, Inda ME, Batra S (2017) Unraveling the role of membrane microdomains during microbial infections. Cell Biol Toxicol 33(5):429–455
Article
PubMed
PubMed Central
Google Scholar
Shevchenko A, Simons K (2010) Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol 11(8):593–598
Article
PubMed
CAS
Google Scholar